BioNanomatrix has named Todd Dickinson vice president of product development and Xing Yang vice president of system integration. The Philadelphia-based biochip firm made the appointments as part of an expansion that included opening a San Diego office.
Dickinson joins BioNanomatrix from Illumina, where he most recently served as director of product development for its DNA sequencing business. Yang previously worked at Epic Sciences where he served as vice president of technology. He also was president of research for Helixis and director of systems development for BD Diagnostics-GeneOhm.
Sequenom has appointed Charles Slacik to serve on its board of directors. Slacik is currently chief financial officer and senior vice president at Beckman Coulter.
Prior to Beckman, Slacik was executive VP and CFO at Watson Pharmaceuticals and senior VP and CFO at the medical technologies company CR Bard.